Blog

Ascend Acquires GMP Facility Boosts Gene Therapy
📢 Ascend Advanced Therapies secures Beacon Therapeutics' GMP facility in Florida, boosting gene therapy expertise and product supply. 🔬🤝👁️

Game-Changing Acquisition: Essential Pharma Takes Over Renaissance Pharma to Revolutionize Pediatric Neuroblastoma Treatment
📢 Essential Pharma acquires Renaissance Pharma Ltd to commercialize Phase II program Hu14.18K322A, showing promising results in pediatric high-risk neuroblastoma.

French Company Receives $6m Grant to Fight Malaria
📢 French company Medincell Corp awarded $6m grant by Unitaid to fund safety testing of its malaria vaccine mdc-STM. 🌍🦟

Revolutionary Advances in Stem Cell Research
🧬 Advances in Induced Pluripotent Stem Cell Research explores the power of flow cytometry for stem cell studies. 🔬 📅 (20 words)

Lonza Partners with Acumen for Alzheimer’s Breakthrough
📰 Lonza teams up with Acumen to make sabirnetug, a groundbreaking Alzheimer's therapy, at their New Hampshire facility. 👥 🧪 Sabirnetug targets toxic amyloid beta oligomers, offering hope in the fight against Alzheimer's. 💡 ⏩ Exciting collaboration to speed up Alzheimer's treatment development. Lonza Acumen AlzheimersTherapy Sabirnetug

Genmab’s $18bn Acquisition Boosts Cancer Pipeline
💥 Genmab is acquiring ProfoundBio for $1.8bn to expand its pipeline of antibody-drug conjugate therapies. 💊🏭🚀

Expand Your Biopharmaceutical Skills with Asahi Kasei Bioprocess’ Cutting-Edge Training!
✨ Asahi Kasei Bioprocess' Massachusetts Training Center (MTC) expands its 2024 course offerings, covering various bioprocess topics. 🎓🔬📚🖥️💼🌐

Discover How Biosimilar Charge Variants Affect Drug Potency
Discover how charge variants in biosimilars can impact drug stability and potency, and the importance of demonstrating similarity. 🔬⚖️🧪







